An ongoing dialogue on HIV/AIDS, infectious diseases,
October 8th, 2024
Why We Have Antibiotic Shortages and Price Hikes — And What One Very Enterprising Doctor Did in Response
At the start of our weekly case conference, we get announcements from one of our ID pharmacists. New drug approvals, hospital policies, updated guidelines — that kind of thing. But over the last decade or so, the most common topic they’ll comment on is the latest important antibiotic shortage. For those not in medicine, you […]
Paul E. Sax, MD
Contributing Editor
NEJM Journal Watch
Infectious Diseases
Biography | Disclosures | Summaries
Learn more about HIV and ID Observations.
NEJM Journal Watch — Recent Infectious Disease Articles- Observations from ID and Beyond: Why We Have Antibiotic Shortages and Price Hikes — And What One Very Enterprising Doctor Did in Response
- Mpox Containment Measures: Still Room for Improvement
- Serotonin Syndrome as a Consequence of Antimicrobial Use
- The Remarkable Success of Childhood Vaccination in the U.S.
- Antimicrobial Therapy Against Sepsis Caused by Pseudomonas aeruginosa: Two Punches or One?